Literature DB >> 198893

[Bismuth treatment and blood bismuth levels].

P Hillemand, M Pallière, B Laquais, P Bouvet.   

Abstract

The authors report the results of bismuth blood levels in 41 patients treated by oral route with bismuth salts used in gastro-enterology according to the Bensaude rule (10 to 20 g/day, 20 days/month). Median bismuth blood level during the period of treatment amounts to 13 microgram/l. It decreases to 7 microgram/l during the period of therapeutic withdrawal. In patients with bismuth encephalopathies (63 cases recorded in the literature) median values range from 680 to 700 microgram/l. The authors recommend the determination of bismuth blood levels as a monitoring method in bismuth treatment and propose the following values:--normal level during treatment : less than 50 microgram/l (in Bi metal);--alarm level : 50 to 100 microgram/l : (patients to be monitored);--toxicity level less than 100 microgram/l : (treatment to be interrupted).

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 198893

Source DB:  PubMed          Journal:  Sem Hop


  16 in total

1.  D-penicillamine does not increase urinary bismuth excretion in patients treated with tripotassium dicitrato bismuthate.

Authors:  C U Nwokolo; R E Pounder
Journal:  Br J Clin Pharmacol       Date:  1990-10       Impact factor: 4.335

2.  Campylobacter pyloridis and associated gastritis: investigator blind, placebo controlled trial of bismuth salicylate and erythromycin ethylsuccinate.

Authors:  C A McNulty; J C Gearty; B Crump; M Davis; I A Donovan; V Melikian; D M Lister; R Wise
Journal:  Br Med J (Clin Res Ed)       Date:  1986-09-13

3.  The challenge of Helicobacter pylori resistance to antibiotics: the comeback of bismuth-based quadruple therapy.

Authors:  Francis Mégraud
Journal:  Therap Adv Gastroenterol       Date:  2012-03       Impact factor: 4.409

4.  [Monoamine metabolites and cyclic nucleotides in the cerebrospinal fluid of patients with bismuth or mercury poisoning].

Authors:  H Cramer; B Renaud; M Billiard; J Mouret; R Hammers
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1978-12-14

5.  Antacids for duodenal ulcer.

Authors:  J R Murray
Journal:  Br Med J (Clin Res Ed)       Date:  1981-07-04

Review 6.  Toxic substances and the nervous system: the role of clinical observation.

Authors:  P M Le Quesne
Journal:  J Neurol Neurosurg Psychiatry       Date:  1981-01       Impact factor: 10.154

7.  Twice daily tripotassium dicitrato bismuthate in the treatment of duodenal ulceration.

Authors:  D Hollanders
Journal:  Postgrad Med J       Date:  1986-01       Impact factor: 2.401

8.  Prevention of traveler's diarrhea by the tablet form of bismuth subsalicylate.

Authors:  R Steffen; H L DuPont; R Heusser; A Helminger; F Witassek; M D Manhart; M Schär
Journal:  Antimicrob Agents Chemother       Date:  1986-04       Impact factor: 5.191

9.  Comparative pharmacokinetics of bismuth from ranitidine bismuth citrate (GR122311X), a novel anti-ulcerant and tripotassium dicitrato bismuthate (TDB).

Authors:  L F Lacey; N M Frazer; O N Keene; J T Smith
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

10.  Randomised open controlled trial of colloidal bismuth subcitrate tablets and cimetidine in the treatment of duodenal ulcer.

Authors:  G Vantrappen; P Rutgeerts; L Broeckaert; J Janssens
Journal:  Gut       Date:  1980-04       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.